Pharmacological

PreclinicalSmall molecule

UUniversity of Virginia

Pharmacological is one of 10 small molecule programs targeting Smokers. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

SmokersCompleted

OpioidsCompleted

SmokersPreclinical

Completed

OpioidsPreclinical

Completed

Competition

Competitive Landscape

7 competitors in Smokers

#DrugCompanyPhaseTrials

Chantix

Pfizer

Phase 3

3 2

Epivir

GGlaxo Dba Glaxosmithkline

Phase 1

1 3

Rapamycin

MMaastricht Radiation Oncology

Phase 1

1 4

Nicotine Lozenge

FFertin Pharma A/S

Preclinical

1 5

Pharmacological

UUniversity of Virginia

Preclinical

1 6

Reduced Nicotine Content Cigarettes

MMilton S. Hershey Medical Center

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Smokers1 trial

Strategies to Promote Cessation in Smokers Who Are Not Ready To Quit

Completed·UUniversity of Virginia·N/A·NCT02905656·903 enrolled

Opioids1 trial

Care Management for the Effective Use of Opioids

Completed·VVA Office of Research and Development·N/A·NCT01236521·261 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Pharmacological. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Pharmacological compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Pharmacological. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Virginia company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity of Virginia

Pharmacological

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Smokers1 trial

Opioids1 trial

References

Drug Info

Quick Facts

Related News